Feasibility Study - Neofact
Launched by UNIVERSITY HOSPITAL TUEBINGEN · Sep 9, 2019
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Preterm infants with respiratory distress syndrome and the need for Surfactant administration (oxygen requirement with FiO2 ≥ 30% and/or mod. Silverman Andersen Respiratory Severity Score (RSS) ≥ 5)
- • Respiratory support with non-invasive CPAP at the time of Surfactant administration
- Exclusion Criteria:
- • Preterms with an gestational age \< 26+0 weeks
- • Preterms with malformations of the respiratory tract
- • Clinical decision on intubation / surfactant application via endotracheal tube e.g. because of respiratory drive disorder
- • (Missing parental consent)
- • (Attending physician is not delegated by the principal investigator)
About University Hospital Tuebingen
University Hospital Tübingen is a leading academic medical institution in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its multidisciplinary expertise and cutting-edge facilities to develop new therapeutic strategies and improve patient outcomes. With a strong focus on translational medicine, University Hospital Tübingen collaborates with various stakeholders, including pharmaceutical companies and research organizations, to facilitate the efficient and ethical conduct of trials across a wide range of medical disciplines. Their dedication to patient-centered research and rigorous scientific standards positions them at the forefront of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stuttgart, Baden Wuerttemberg, Germany
Tuebingen, Baden Wuerttemberg, Germany
Patients applied
Trial Officials
Christian A. Maiwald, Dr.
Study Chair
Department of Neonatology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials